As a clinician who treats veterans struggling with trauma, mental illness, and addiction, I’m careful about language. Words ...

Early smoking cessation post-cancer diagnosis significantly improves survival, with optimal benefits seen when quitting within 6 months. The Tobacco Research and Treatment Program at MD Anderson ...

Please provide your email address to receive an email when new articles are posted on . Integrated care of nicotine replacement, pharmacotherapy and counseling proved most durable for smoking ...

Smoking cessation in cancer patients is a critical area of investigation that addresses both the improvement of treatment outcomes and overall survival. Although smoking is the primary risk factor for ...

MINNEAPOLIS/ST. PAUL (08/24/2023) —Lung cancer is the deadliest cancer in the United States, and 80% of lung cancer deaths are linked to one risk factor: smoking. While lung cancer screenings are a ...

Eight counseling sessions with short-course nicotine replacement therapy delivered the best value per quit in a lung cancer ...

Wearable technology has had a dramatic impact on many areas of life. This has been driven by the transformation of the Internet from a people-to-people to a device-to-device (and even thing-to-thing) ...

September 28, 2011 — Cytisine (Tabax, Sopharma AD) may be an effective and ultimately inexpensive aid in smoking cessation, new research suggests. A randomized, controlled trial of more than 700 ...

Smokers who quit after a cancer diagnosis had increased survival, with the greatest benefit for those who initiated smoking cessation treatment within 6 months, a prospective cohort study showed.

Starting smoking cessation treatment within 9 months of a cancer diagnosis was associated with improved survival across various cancer types, with the greatest survival benefit observed among patients ...

Please provide your email address to receive an email when new articles are posted on . Quitting smoking within 6 months of cancer diagnosis reduced risk for all-cause mortality by nearly half. The ...

IQWiG has now published its final benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation, also in combination with each other, compared with no drug therapy.